This hypothesis is supported by the observation that the development of resistance to EGFR inhibition is associated with downregulation of mismatch and homologous recombination repair proteins resulting in error-prone DNA repair and increased tumor variagenic ability.22 This evidence concerns the gene EGFR and neoplasm.